CINXE.COM

{"title":"Intellectual Property Protection of CRISPR Related Technologies","authors":"Zheng Miao, Dennis Fernandez","volume":131,"journal":"International Journal of Bioengineering and Life Sciences","pagesStart":591,"pagesEnd":597,"ISSN":"1307-6892","URL":"https:\/\/publications.waset.org\/pdf\/10008148","abstract":"CRISPR research has the potential to completely transform life science, agriculture, live-stock and the health care industry. The Intellectual Property derived from its research has raised significant attention in the academic as well as the biopharmaceutical industry culminating an urgent need for strategic IP protection. We review the rudimentary concepts and key competitors of CRISPR technologies as well as the paramount strategies for intellectual property protection. Further, we elaborate on prosecution issues related to CRISPR patents as well as possible solutions to various patent laws, interferences and litigation. Finally, we address how the bioinformatics of the CRISPR technology begs an inquiry into issues of privacy and a host of ethical concerns.","references":"[1]\tM. Jinek, K. Chylinski, I. Fonfara, et al. \u201cProgrammable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.\u201d Science, vol. 337, Aug. 2012, pp. 816-821.\r\n[2]\tK. Chylinski, K. S. Makarova, E. Charpentier, and E. V. Koonin, \u201cClassification and evolution of type II CRISPR-Cas systems.\u201d Nucleic Acids Res., vol 42, Jun. 2014, pp. 6091\u20136105.\r\n[3]\tI. Fonfara, H. Richter, M. Bratovi\u010d, A. Le Rhun, E. Charpentier, \u201cThe CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.\u201d Nature, vol. 532, Apr. 2016, pp. 517-521. \r\n[4]\tL. Cong, F. A. Ran, Cox, D., et al. \u201cMultiplex genome engineering using CRISPR\/Cas systems.\u201d Science. vol. 339, Feb. 2013, pp. 819-823. \r\n[5]\tP. Mali, L. Yang, K. M. Esvelt, et al. \u201cRNA-guided human genome engineering via Cas9.\u201d Science, vol. 339, Feb. 2013, pp. 823-826.\r\n[6]\tM. Jinek, A. East, A. Cheng, et al. \u201cRNA-programmed genome editing in human cells.\u201d Elife, Jan. 2013, e00471. doi: 10.7554\/eLife.00471. \r\n[7]\tX. Han, Z. Liu, M. C. Jo, et al. \u201cCRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation.\u201d Sci Adv., vol. 1, Aug. 2015, e1500454. doi: 10.1126\/sciadv.1500454. \r\n[8]\tLeahy-Smith America Invents Act. United States Code Title 35. \u00a7\u00a7 101-103. USPTO MPEP Appendix L - Patent Laws CHAPTER 10. \u201cPatentability of inventions\u201d, Sept. 2011.\r\n[9]\tU.S. PATENT AND TRADEMARK OFFICE. Types of Patents. www.uspto.gov\/web\/offices\/ac\/ido\/oeip\/taf\/patdesc.htm. Accessed on 16\/03\/2017.\r\n[10]\tD. Fernandez, C. Chun, \u201cIntellectual property protection in the EDA industry\u201d. International journal of novel research in marketing management and economics, vol. 2, 2015, pp. 55-63. \r\n[11]\tRichards Patent Law, How much does a patent cost? http:\/\/www.richardspatentlaw.com\/faq\/have-an-idea\/how-much-does-apatent-cost\/, 2012. Accessed on 16\/03\/2017.\r\n[12]\tS. Halpern, Copyright Law: Protection of original expression (Carolina Academic Press, 2002.\r\n[13]\tK. Chan, D. S. Fernandez, \u201cPatent Prosecution in Proteomics.\u201d Computer & high technology law journal, vol. 19, 2003, pp. 458-470.\r\n[14]\tD. Fernandez, A. Maninang, S. Kobayashi, et al. \u201cIntellectual Property Protection for Bioinformatics and Computational Biology.\u201d IWBBIO, 2015, Part I, LNCS 9043, pp. 85\u201395. \r\n[15]\tH. C. Anawalt, E. E. Powers, IP Strategy \u2013 Complete intellectual property planning, access, and protection, West Group, \u00a71.01, at 1-3, 2001.\r\n[16]\tGenome editing\/genome engineering market by technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021. Published in Oct. 2016.\r\n[17]\tK. Pardee, A. A. Green, M. K. Takahashi et al. \u201cRapid, low-cost detection of Zika virus using programmable biomolecular components.\u201d Cell, vol. 165, May 2016, pp. 1255-1266. doi: 10.1016\/j.cell.2016.04.059. \r\n[18]\tM. K. Kiessling, S. Schuierer, S. Stertz, et al. \u201cIdentification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.\u201d BMC Genomics, vol. 17, Sept. 2016, pp. 723. doi: 10.1186\/s12864-016-3042-2.\r\n[19]\tS. Ellis, Toolgen wins critical CRISPR patent in Korea. http:\/\/www.bioworld.com\/content\/toolgen-wins-critical-crispr-patent-korea-0. Accessed on 16\/03\/2017.\r\n[20]\t J. J. Yeh, D. Fernandez, N. Hansen, \u201cPatent prosecution strategies for stem cell-related applications.\u201d APBN, vol. 9, 2005, pp. 1212-1219.\r\n[21]\tR. Kumar, J. J. Yeh, D. Fernandez, N. Hansen, Patent prosecution strategies for stem cell\u2013related applications. Journal of Biomolecular Screening, vol. 12, 2007, pp. 769-774. doi: 10.1177\/1087057107305828.\r\n[22]\thttps:\/\/acts.uspto.gov\/ifiling\/PublicView.jsp?identifier=106048&identifier2=null&tabSel=1&action=filewrapper&replyTo=PublicView.jsp. Accessed on 16\/03\/2017.\r\n[23]\tEthicon, INC. vs U.S. Surgical Corporation, Fed. Cir., 1998 (135 F.3d 145645 U.S.P.Q.2d 1545, 48 Fed. R. Evid. Serv. 1226). \r\n[24]\tJ. Wu, A. Platero-Luengo, M. Sakurai, et al. \u201cInterspecies chimerism with mammalian pluripotent stem cells.\u201d Cell, vol. 168, 2017, pp. 473. doi: 10.1016\/j.cell.2016.12.036\r\n[25]\tJ. Mun, D. U. Kim, K. L. Hoe, S. Y. Kim, \u201cGenome-wide functional analysis using the barcode sequence alignment and statistical analysis (Barcas) tool.\u201d BMC Bioinformatics. Vol. 17(Suppl 17), Dec. 2016 , pp. 475. \r\n[26]\tO. Parnas, M. Jovanovic, T. M. Eisenhaure, et al. \u201cA Genome-wide CRISPR screen in primary immune cells to dissect regulatory networks.\u201d Cell, vol. 162, July 2015, pp. 675-686. doi: 10.1016\/j.cell.2015.06.059.\r\n[27]\tAlice Corporation v. CLS Bank International, 573 U.S. ____ (2014) (June 2014).","publisher":"World Academy of Science, Engineering and Technology","index":"Open Science Index 131, 2017"}